Metformin and Body Mass Index of Patients under Treatment with SSRI

Phase 3

Recruiting

• Conditions: E66.1; F32.2; Condition 1: Obesity. Condition 2: Depression. Condition 3: Anxiety Disorders.; Drug-induced obesity; Major depressive disorder, single episode, severe without psychotic features; Other anxiety disorders

• Registration Number: IRCT20140102016035N3
• Lead Sponsor: Rasht University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Obtain informed consent from patients
No history of side effects with metformin and SSRI drugs
The absence of kidney and liver disorders
The absence of a physical illness such as diabetes and Autoimmune disease
No taking Corticosteroids
Not taking any type of drug and stimulant
The absence of psychotic features

Exclusion Criteria

Addiction
Having metabolic disorders

Study & Design

• Study Type: interventional
• Study Design: Not specified